In the rapidly expanding weight-loss drug market, telehealth provider Hims & Hers Health, Inc. (NYSE:HIMS) has found a niche by offering affordable alternatives to popular anti-obesity medications like Eli Lilly And Co’s (NYSE:LLY) Zepbound and Novo Nordisk A/S’ (NYSE:NVO) Wegovy.
These…
